|
Drug Eluting Stents
Benefits of Retaining
Monheit Law for your Drug Eluting Stent Lawsuit?
Finding a law firm is not easy. Find out what Monheit Law has to offer you.
www.monheit.com/benefits.asp
Stent FAQs
Can I afford a DES lawsuit? Is the FDA aware of the dangerous DES side effects?
How does a drug eluting stent work? How long does it take for a drug eluting
stent to dissolve? Do stents have to be permanent?
www.monheit.com/faqs.asp
Stent Resources on the Web
Other sites that contain information on
drug eluting stents.
www.monheit.com/web.asp
Do I have a
case?
|
 |
Drug Eluting Stents: Medical Miracle or
Blood Clot Nightmare
The concern about drug-eluting stents (DES) centers on blood clot thrombosis. A
drug-eluting stent is a stent (think scaffold) placed into narrowed, diseased
coronary arteries that slowly releases a drug to block cell proliferation. This
supposedly prevents the scar tissue-like growth that together with blood clots
could otherwise block the stented artery.
Doctors implant them in the hearts of about a million Americans a year to treat
coronary artery disease. Drug Eluting Stents generate around $5 billion a year
in sales for Abbott Laboratories, Medronic, Boston Pharmaceuticals, and Johnson
& Johnson, the companies who manufacture them.
Drug eluting stents may be doing more harm than good. Do you have a DES lawsuit?
At the end of 2006, a panel of experts will try to advise the Food and Drug
Administration on what to do about DES. Today, the scope of the DES problem is
unknown. By one estimate the stents already kill 2,000 Americans a year. Many
top doctors and scientists admit that drug eluting stents are a frightening
problem that has been greatly unanticipated and no one knows what the long-term
danger will be.
Coronary artery stents, typically a metal framework, can be placed inside the
artery to help keep it open. However, the stent is a foreign object that incites
an immune response. This may cause scar tissue or cell proliferation to rapidly
grow over the stent. Additionally, there is a strong tendency for clots to form
at the site where the stent damages the arterial wall.
Drug-eluting stents have been shown to be superior for many of the conditions
that traditional bare metal stents have been used for. They have been highly
successful at treating coronary heart disease and offer significant advantages
over other therapies, such as surgery. Since being approved by the FDA in 2003,
drug-eluting stents have become one of the dominant interventions in preventing
and treating heart attacks, yet with all this hype, the potential for DES caused
blood clot thrombosis, heart attacks, and death is very real.
An example of a drug-eluting stent is the TAXUS™ Express2™ Paclitaxel-Eluting
Coronary Stent System, which releases paclitaxel.
Have you or a loved one experienced a blood clot or fatal heart attack caused by
a drug eluting stents? Do you need a DES lawyer for your DES lawsuit? Contact us
today for your free legal consultation.
|
 |
